Balaji Amines Ltd
Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]
- Market Cap ₹ 7,045 Cr.
- Current Price ₹ 2,174
- High / Low ₹ 3,267 / 1,873
- Stock P/E 41.6
- Book Value ₹ 432
- Dividend Yield 0.46 %
- ROCE 23.8 %
- ROE 17.6 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Debtor days have improved from 73.1 to 55.2 days.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
447 | 509 | 608 | 602 | 632 | 665 | 858 | 947 | 918 | 1,227 | 1,914 | 1,720 | 1,549 | |
367 | 429 | 517 | 500 | 503 | 513 | 676 | 753 | 738 | 901 | 1,473 | 1,391 | 1,298 | |
Operating Profit | 81 | 80 | 91 | 102 | 129 | 151 | 182 | 193 | 180 | 327 | 441 | 330 | 251 |
OPM % | 18% | 16% | 15% | 17% | 20% | 23% | 21% | 20% | 20% | 27% | 23% | 19% | 16% |
4 | 4 | 3 | 3 | 2 | 9 | 12 | 5 | 10 | 12 | 18 | 10 | 11 | |
Interest | 21 | 25 | 32 | 31 | 20 | 12 | 9 | 13 | 12 | 5 | 7 | 3 | 2 |
Depreciation | 10 | 13 | 16 | 19 | 18 | 18 | 19 | 20 | 24 | 23 | 29 | 31 | 32 |
Profit before tax | 53 | 46 | 46 | 56 | 93 | 130 | 166 | 166 | 154 | 310 | 423 | 305 | 229 |
Tax % | 32% | 32% | 27% | 35% | 34% | 34% | 32% | 29% | 26% | 25% | 27% | 25% | |
36 | 31 | 34 | 36 | 61 | 86 | 113 | 118 | 114 | 232 | 308 | 228 | 169 | |
EPS in Rs | 11.01 | 9.62 | 10.35 | 11.22 | 18.91 | 26.41 | 34.93 | 36.44 | 35.11 | 71.51 | 95.04 | 70.23 | 52.26 |
Dividend Payout % | 7% | 14% | 10% | 11% | 11% | 8% | 7% | 8% | 9% | 6% | 6% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 15% |
3 Years: | 23% |
TTM: | -24% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | 15% |
3 Years: | 26% |
TTM: | -47% |
Stock Price CAGR | |
---|---|
10 Years: | 52% |
5 Years: | 36% |
3 Years: | 39% |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | 23% |
5 Years: | 23% |
3 Years: | 25% |
Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |
Reserves | 140 | 166 | 196 | 231 | 285 | 371 | 461 | 569 | 661 | 891 | 1,186 | 1,394 |
216 | 209 | 262 | 236 | 159 | 103 | 115 | 95 | 102 | 0 | 0 | 0 | |
105 | 139 | 158 | 129 | 156 | 175 | 237 | 327 | 334 | 394 | 292 | 151 | |
Total Liabilities | 467 | 520 | 621 | 603 | 607 | 655 | 819 | 997 | 1,104 | 1,292 | 1,484 | 1,551 |
196 | 234 | 325 | 321 | 322 | 309 | 316 | 318 | 363 | 344 | 495 | 604 | |
CWIP | 25 | 63 | 8 | 3 | 16 | 25 | 66 | 63 | 46 | 173 | 141 | 74 |
Investments | 9 | 21 | 21 | 30 | 30 | 30 | 66 | 66 | 114 | 66 | 66 | 128 |
238 | 203 | 268 | 249 | 238 | 292 | 371 | 550 | 581 | 708 | 782 | 745 | |
Total Assets | 467 | 520 | 621 | 603 | 607 | 655 | 819 | 997 | 1,104 | 1,292 | 1,484 | 1,551 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
53 | 94 | 111 | 60 | 84 | 72 | 126 | 89 | 148 | 94 | 176 | 216 | |
-56 | -86 | -50 | -14 | -30 | -23 | -93 | -47 | -130 | -87 | -142 | -132 | |
-1 | -10 | -53 | -49 | -52 | -54 | -29 | -29 | -31 | 3 | -20 | -22 | |
Net Cash Flow | -5 | -2 | 7 | -3 | 2 | -5 | 4 | 13 | -13 | 10 | 14 | 61 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 67 | 74 | 79 | 70 | 69 | 67 | 73 | 64 | 76 | 81 | 83 | 55 |
Inventory Days | 149 | 66 | 87 | 93 | 62 | 88 | 70 | 100 | 66 | 56 | 69 | 97 |
Days Payable | 48 | 42 | 83 | 46 | 57 | 55 | 56 | 58 | 40 | 43 | 57 | 13 |
Cash Conversion Cycle | 168 | 99 | 83 | 117 | 74 | 100 | 87 | 106 | 102 | 94 | 95 | 139 |
Working Capital Days | 121 | 75 | 67 | 85 | 58 | 67 | 71 | 82 | 87 | 80 | 80 | 98 |
ROCE % | 23% | 19% | 18% | 19% | 24% | 30% | 33% | 29% | 23% | 38% | 41% | 24% |
Documents
Announcements
- Closure of Trading Window 8h
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 Sep
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
15 Sep - Submission of Q1FY24 Earnings Call Transcript under Regulation 30 of SEBI (LODR) Regulations, 2015
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
8 Sep - Audio Recording of Conference Call held on 8th September, 2023 to discuss Q1FY24 Financial Results.
- Announcement Under Regulation 30 (LODR) - Intimation Regarding Withdrawal Of The Draft Red Herring Prospectus Dated August 10, 2022 ("DRHP") Filed With The SEBI ('SEBI') By Balaji Speciality Chemicals Limited ('BSCL') 8 Sep
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Concalls
-
Sep 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jul 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Jan 2020TranscriptNotesPPT
-
Dec 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
Jul 2019Transcript PPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Feb 2018TranscriptPPT
-
Feb 2017TranscriptPPT
-
Feb 2017TranscriptPPT
Product Portfolio[1]
The company has a diversified product portfolio with a basket of over 30 different products. These products are categorised under 3 main categories i.e. Amines, Amine derivatives and Specialty & Other chemicals. Its products includes Methyl Amines, Ethyl amines, Amino Ethanol, acetamide, amine hydrochloride, methyl urea, choline chloride, morpholine, etc.
Its products find application in many industries like Pharma, Agro, Rubber chemicals, photographic chemicals, rocket fuel, pesticides, solvents, performance chemicals, water treatment chemicals, etc.